Kamada (KMDA) CEO reports trustee-held option grants and cancellations
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Kamada Ltd Chief Executive Officer Amir London reported a series of compensation-related option changes, not open-market trading. A trustee under Kamada’s 2011 Share Award Plan received several grants of employee stock options for 100,000 ordinary shares each at exercise prices such as $5.87 and $7.25, while matching 100,000-option awards at $6.12 and $7.50 were returned to the company.
According to the notes, the exercise prices were adjusted under the 2011 Share Award Plan after a cash dividend declared on March 11, 2026, with no other changes to the award terms. The options vest in four equal annual installments and are held by a trustee under the plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
16 transactions reported
Mixed
16 txns
Insider
London Amir
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 100,000 | $0.00 | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 100,000 shares (Indirect, Held by trustee)
Footnotes (1)
- All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan.
Key Figures
Option grant size: 100,000 options
Exercise price (series 1): $5.87 per share
Exercise price (series 2): $6.12 per share
+4 more
7 metrics
Option grant size
100,000 options
Each employee stock option award for ordinary shares
Exercise price (series 1)
$5.87 per share
Employee stock options after adjustment, various grant dates
Exercise price (series 2)
$6.12 per share
Employee stock options returned to issuer
Exercise price (series 3)
$7.25 per share
Employee stock options after adjustment, later expirations
Exercise price (series 4)
$7.50 per share
Employee stock options returned to issuer
Expiration date (first group)
June 22, 2029
Options linked to 2023–2026 exercise dates
Expiration date (later group)
December 10, 2035
Options linked to 2026–2029 exercise dates
Key Terms
Employee Stock Option (right to buy), Disposition to issuer, 2011 Share Award Plan, exercise price, +2 more
6 terms
Employee Stock Option (right to buy) financial
"security_title: "Employee Stock Option (right to buy)""
Disposition to issuer financial
"transaction_code_description: "Disposition to issuer""
exercise price financial
"The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
cash dividend distribution financial
"in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026."
vesting financial
"Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What insider transactions did Kamada (KMDA) report for CEO Amir London?
Kamada reported that a trustee for CEO Amir London received several grants of 100,000 employee stock options while returning matching 100,000-option awards to the company. These transactions involved option grant acquisitions and dispositions to the issuer, not open-market share purchases or sales.
What are the key option exercise prices in Kamada (KMDA) CEO’s Form 4 filing?
The filing lists employee stock options with exercise prices of $5.87, $6.12, $7.25, and $7.50 per ordinary share. Footnotes explain these U.S. dollar amounts reflect conversions from NIS using a Bank of Israel exchange rate as of April 6, 2026.
Why were Kamada (KMDA) CEO option exercise prices adjusted in this filing?
Footnotes state the option exercise prices were adjusted under Kamada’s 2011 Share Award Plan following a cash dividend distribution declared by the board on March 11, 2026. The company notes there are no other changes to the terms and conditions of the option award.
How do the Kamada (KMDA) CEO options reported here vest over time?
The options reported vest in four equal annual installments, with 25% vesting on each of the four anniversaries of the grant date. This creates a long-term incentive structure aligning the timing of CEO equity benefits with multi-year service at Kamada.
Who legally holds the Kamada (KMDA) CEO options shown in the Form 4?
The Form 4 indicates the options are held indirectly, by a trustee under Kamada’s 2011 Share Award Plan. The nature of ownership is coded as indirect and described in the footnotes as “Held by trustee under the Company’s 2011 Share Award Plan.”